• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
PAN Jing,XIA Jiaxuan,JIN Yibao,TANG Jia,WANG Bing,HUANG Xiaolong.Analysis of degradation pathways and impurities of Losartan Potassium[J].Journal Of Pharmaceutical Research,2024,43(2):128-134[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 2836times   Download 3389次 QR Code for this article
Scan with your phone!
氯沙坦钾原料药降解途径与降解杂质分析
潘静1,夏佳璇2,3,金一宝2,汤佳1,王冰2,黄晓龙1
Font:Larger+|Default|Smaller-
(1.国家药品监督管理局药品审评检查大湾区分中心,广东 深圳 518017;2.深圳市药品检验研究院,国家药品监督管理局仿制药评价生物等效性研究重点实验室,深圳市药品质量标准研究重点实验室,广东 深圳 218057;3.中山大学药学院<深圳>,广东 深圳 518107)
摘要:
目的 通过强制降解试验探讨氯沙坦钾原料药的降解杂质和降解途径。方法 建立氯沙坦钾及其有关物质的高效液相(HPLC)分析方法,采用Waters XBridge BEH C18 (4.6 mm×250 mm, 5 μm)色谱柱,流动相为0.05%磷酸水溶液-乙腈,梯度洗脱,流速为1.0 mL•min-1,柱温设置为30 ℃,检测波长210 nm,对氯沙坦钾降解溶液中主峰含量进行测定,探讨氯沙坦钾原料药在氧化、酸、碱、高温、光照条件下的降解率。结果 在本实验设计的67种降解条件中,氯沙坦钾原料药对氧化(加热和室温)、高温高湿、酸环境敏感,同时在溶液状态下对高温和光照条件敏感。并确定氯沙坦钾强制降解后的4个降解杂质的分子结构及其质谱裂解反应机理。结论 本实验以强制降解中所涉及的多种环境模拟对氯沙坦钾降解过程的研究,研究有助于探索药品贮藏及药品制剂生产中的杂质变化。
关键词:  氯沙坦钾  氧化破坏  酸破坏  碱破坏  高温破坏  光照破坏  降解杂质
DOI:10.13506/j.cnki.jpr.2024.02.005
基金项目:国家“重大新药创制”科技重大专项资助项目(No.2017zx09101001/03/04)
Analysis of degradation pathways and impurities of Losartan Potassium
PAN Jing1,XIA Jiaxuan2,3,JIN Yibao2,TANG Jia1,WANG Bing2,HUANG Xiaolong1
(1. Greater Bay Area Center for Drug Evaluation and Inspection of National Medical Products Administration, Shenzhen 518017, China; 2. Shenzhen Institute for Drug Control, NMPA Key Laboratory for Bioequivalence Research of Generic Drug Evaluation, Shenzhen Key Laboratory of drug Quality Standard Research, Shenzhen 518057, China;3. School of Pharmaceutical Sciences (Shenzhen), Sun Yat-sen university, Shenzhen 518107, China)
Abstract:
Objective Exploring the degradation pathway of losartan potassium Active Pharmaceutical Ingredient (API) through forced degradation test.Methods A high performance liquid chromatographic (HPLC) method was developed for the determination of losartan potassium and its related substances on a Waters X Bridge BEH C18 (4.6 mm×250 mm, 5 μm) column with a mobile phase of 0.05% aqueous phosphoric acid solution-acetonitrile, gradient elution, flow rate of 1.0 mL•min-1, column temperature set at 30 ℃, detection wavelength 210 nm. The content of the main peak in the degradation solution of losartan potassium was determined to explore the degradation rate of losartan potassium API under the conditions of oxidation, acid hydrolysis, alkaline hydrolysis, thermal and photolysis.Results Among the 67 degradation conditions designed for this experiment, Losartan potassium API was sensitive to oxidation (heating and room temperature), high temperature accompanied with high humidity, acidic condition environment, while in solution state it was sensitive to high temperature and light conditions. The molecular structures of four degradation impurities of losartan potassium were determined, and their mass spectrum cleavage reaction mechanisms were clarified.Conclusion This experiment was conducted to simulate the degradation process of losartan potassium with a variety of environments involved in forced degradation. The study helps to explore the changes in impurities in drug storage and drug formulation production for quality control of losartan potassium API and its formulations.
Key words:  Losartan Potassium  Oxidative destroying  Acid destroying  Alkali destroying  High temperature destroying  Light destroying  Degradation impurities
Today's Visits:511    Total Visits:2383242
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.